How leaders are reacting to the Supreme Court's abortion pill ruling

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Healthcare Leaders Are Reacting to the Supreme Court Preserving Abortion Pill Access The Supreme Court sided with the FDA and unanimously ruled to uphold access to abortion pill mifepristone. The decision quells worries about what it might look like if the Supreme Court sided with the physician group — many healthcare leaders feared that if the top court could overturn mifepristone's FDA approval, the same could happen to other drugs. Sponsored Consultants On The Shifting Employer Healthcare Landscape Presented by MedCity News and Quantum Health More than 100 skilled consultants to self-insured employers shared their perspectives on the changing dynamics in healthcare benefits in MedCity News' second annual 2024 Benefit Consultant Sentiment Index. The report functions as an insider's guide to understanding how healthcare trends are shaping employer benefit decisions from the perspective of consultants. INVEST Digital Health, a Boutique Healthcare Conference in Dallas: Why Attend? INVEST Digital Health happening on September 18 at Pegasus Park in Dallas offers a unique opportunity to engage with key stakeholders and explore the latest advancements shaping the future of healthcare.   Connect with healthcare entrepreneurs, investors, and industry experts to exchange ideas, form partnerships, and drive healthcare innovation forward.   Register Now and Save $200

Featured News

AmeriHealth Caritas Exec: Worst Thing Insurers Can Do Is Be Paralyzed by AI Challenges Payers face numerous challenges when it comes to AI, but that doesn't mean they shouldn't use the technology, according to Neil Gomes, senior vice president and chief digital officer of AmeriHealth Caritas. Pfizer & Sarepta Gene Therapies Both Failed Phase 3, But Analysts Expect Sarepta Will Win Approval A Pfizer gene therapy for Duchenne muscular dystrophy failed its Phase 3 clinical trial. But analysts draw distinctions between that therapy and Sarepta Therapeutics' Elevidys, which awaits an FDA decision that could grant it full regulatory approval. How Covered Entities and Pharma Companies Can Better Collaborate on Drug Discount Programs Three things drug manufacturers and CEs can do to build trust and enable effective collaboration The Potential for AI in Drug Design Despite misconceptions about its use, artificial intelligence (AI), through modalities such as machine learning models, is poised to enable companies to expedite the drug design process.

Resources

Debunked| No-Fluff Healthcare News Show | Presented by MedCity News | Episode 5 In this episode, we talk about recent stumbles in primary and virtual care from Walmart, Walgreens, Optum. We also discuss cybersecurity in healthcare and talk about which healthcare sector. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe